Nutex Stock Based Compensation from 2010 to 2024

NUTX Stock

USD 37.20 0.28 0.76%

Nutex Health Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation will likely drop to about 2.1 M in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2010-12-31

Previous Quarter

2.8 M

Current Value

2.1 M

Quarterly Volatility

2.6 M

Credit Downgrade

Yuan Drop

Covid

Check Nutex Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutex Health's main balance sheet or income statement drivers, such as Selling General Administrative of 26.3 M, Total Revenue of 129 M or Gross Profit of 54.7 M, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0037 or PTB Ratio of 1.84. Nutex financial statements analysis is a perfect complement when working with Nutex Health Valuation or Volatility modules.

Check out the analysis of Nutex Health Correlation against competitors.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

Latest Nutex Health's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Nutex Health over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Nutex Health's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nutex Health's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Nutex Stock Based Compensation Regression Statistics

	Arithmetic Mean	1,619,652
	Geometric Mean	459,174
	Coefficient Of Variation	158.54
	Mean Deviation	1,522,121
	Median	924,326
	Standard Deviation	2,567,787
	Sample Variance	6.6T
	Range	10.3M
	R-Value	0.43
	Mean Square Error	5.8T
	R-Squared	0.19
	Significance	0.11
	Slope	247,327
	Total Sum of Squares	92.3T

Nutex Stock Based Compensation History

	2024	2.1 M
	2023	2.8 M
	2022	189.6 K
	2021	10.3 M
	2020	2.6 M
	2019	450.1 K
	2018	208 K

Other Fundumenentals of Nutex Health

Stock Based Compensation To Revenue

Nutex Health Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Current Deferred Revenue	Common Stock	Short Term Debt	Intangible Assets	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Capital Stock	Capital Surpluse
Total Assets		0.9	0.97	-0.67	0.95	0.86	0.76	0.98	0.88	-0.51	0.86	0.55	0.67	0.86	0.17	0.72	0.06	0.86	0.03	0.72	-0.55
Total Stockholder Equity	0.9		0.77	-0.35	0.77	0.96	0.47	0.79	0.98	-0.46	0.69	0.45	0.36	0.9	0.43	0.91	0.16	0.92	0.3	0.37	-0.16
Net Debt	0.97	0.77		-0.82	0.96	0.71	0.88	1.0	0.74	-0.5	0.88	0.58	0.81	0.73	-0.04	0.53	0.05	0.71	-0.19	0.85	-0.68
Retained Earnings	-0.67	-0.35	-0.82		-0.82	-0.24	-0.98	-0.81	-0.28	0.3	-0.76	-0.28	-0.99	-0.3	0.53	-0.04	-0.11	-0.29	0.68	-0.95	0.75
Accounts Payable	0.95	0.77	0.96	-0.82		0.68	0.9	0.97	0.72	-0.44	0.96	0.36	0.84	0.77	-0.05	0.55	-0.06	0.74	-0.15	0.87	-0.69
Net Receivables	0.86	0.96	0.71	-0.24	0.68		0.34	0.73	0.99	-0.5	0.57	0.49	0.22	0.93	0.61	0.94	0.21	0.95	0.42	0.3	-0.19
Good Will	0.76	0.47	0.88	-0.98	0.9	0.34		0.87	0.39	-0.33	0.86	0.29	0.99	0.43	-0.44	0.17	0.01	0.4	-0.55	0.97	-0.75
Total Liab	0.98	0.79	1.0	-0.81	0.97	0.73	0.87		0.76	-0.49	0.9	0.55	0.8	0.75	-0.02	0.56	0.04	0.74	-0.16	0.84	-0.66
Total Current Assets	0.88	0.98	0.74	-0.28	0.72	0.99	0.39	0.76		-0.47	0.62	0.47	0.28	0.93	0.54	0.93	0.2	0.95	0.37	0.33	-0.18
Current Deferred Revenue	-0.51	-0.46	-0.5	0.3	-0.44	-0.5	-0.33	-0.49	-0.47		-0.37	-0.42	-0.25	-0.45	-0.18	-0.41	-0.14	-0.46	-0.06	-0.3	0.23
Common Stock	0.86	0.69	0.88	-0.76	0.96	0.57	0.86	0.9	0.62	-0.37		0.24	0.83	0.71	-0.13	0.47	-0.28	0.64	-0.13	0.84	-0.66
Short Term Debt	0.55	0.45	0.58	-0.28	0.36	0.49	0.29	0.55	0.47	-0.42	0.24		0.21	0.28	0.04	0.24	0.13	0.29	-0.05	0.27	-0.2
Intangible Assets	0.67	0.36	0.81	-0.99	0.84	0.22	0.99	0.8	0.28	-0.25	0.83	0.21		0.32	-0.54	0.06	-0.01	0.29	-0.63	0.96	-0.74
Net Tangible Assets	0.86	0.9	0.73	-0.3	0.77	0.93	0.43	0.75	0.93	-0.45	0.71	0.28	0.32		0.59	0.92	-0.03	0.98	0.47	0.44	-0.4
Long Term Debt	0.17	0.43	-0.04	0.53	-0.05	0.61	-0.44	-0.02	0.54	-0.18	-0.13	0.04	-0.54	0.59		0.75	0.12	0.62	0.9	-0.38	0.2
Net Invested Capital	0.72	0.91	0.53	-0.04	0.55	0.94	0.17	0.56	0.93	-0.41	0.47	0.24	0.06	0.92	0.75		0.16	0.96	0.61	0.12	-0.05
Short Long Term Debt	0.06	0.16	0.05	-0.11	-0.06	0.21	0.01	0.04	0.2	-0.14	-0.28	0.13	-0.01	-0.03	0.12	0.16		0.13	-0.28	-0.1	0.25
Net Working Capital	0.86	0.92	0.71	-0.29	0.74	0.95	0.4	0.74	0.95	-0.46	0.64	0.29	0.29	0.98	0.62	0.96	0.13		0.45	0.39	-0.33
Property Plant Equipment	0.03	0.3	-0.19	0.68	-0.15	0.42	-0.55	-0.16	0.37	-0.06	-0.13	-0.05	-0.63	0.47	0.9	0.61	-0.28	0.45		-0.48	0.27
Capital Stock	0.72	0.37	0.85	-0.95	0.87	0.3	0.97	0.84	0.33	-0.3	0.84	0.27	0.96	0.44	-0.38	0.12	-0.1	0.39	-0.48		-0.9
Capital Surpluse	-0.55	-0.16	-0.68	0.75	-0.69	-0.19	-0.75	-0.66	-0.18	0.23	-0.66	-0.2	-0.74	-0.4	0.2	-0.05	0.25	-0.33	0.27	-0.9

Click cells to compare fundamentals

About Nutex Health Financial Statements

Nutex Health investors use historical fundamental indicators, such as Nutex Health's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nutex Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	2.8 M	2.1 M
Stock Based Compensation To Revenue	0.01	0.01

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nutex Stock Based Compensation from 2010 to 2024

Latest Nutex Health's Stock Based Compensation Growth Pattern

Nutex Stock Based Compensation Regression Statistics

Nutex Stock Based Compensation History

Other Fundumenentals of Nutex Health

Nutex Health Stock Based Compensation component correlations

About Nutex Health Financial Statements

Also Currently Popular

Additional Tools for Nutex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY